Recon

Opioid use does not impair reverse shoulder arthroplasty success

By Lucy Piper, Senior medwireNews Reporter

Taking opioids prior to reverse shoulder arthroplasty does not hamper patients’ chances of having successful outcomes, researchers have found.

They report similar improvements in shoulder function and range of motion for patients irrespective of whether or not they took opioids before surgery, even though baseline scores were better for those with no prior opioid use.

“The key is to establish a preoperative baseline and understand that a ‘one size fits all’ approach does not apply”, say the researchers led by Brent Morris (Texas Orthopedic Hospital, Houston, USA).

“Patients with a history of preoperative opioid use can obtain significant preoperative-to-postoperative improvements; yet, they should not be expected to reach the same peak outcome scores as patients without a history of preoperative opioid use.”

READ THE REST HERE

 

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button